Back to search

Article

Formoterol improves the deficits of mitochondrial homeostasis including dynamic and transport in human SH-SY5Y neuroblastoma cells induced by mitochondrial UQCRC1 mutation in human neuronal SH-SY5Y cells via a β2-adrenoreceptor activation

2023-08-21

Abstract excerpt

Formoterol, a β2-adrenergic receptor (β2AR) agonist, has been showed to support mitochondrial biogenesis in various diseases. However, its efficacy is controversial in Parkinson’s disease (PD) and its regulatory mechanism of mitochondrial homeostasis remains unclear. This study used a cell model of human reductase core protein (UQCRC1) variants in familial parkinsonism, which expressed mitochondrial dysfunction an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
06bd29c9-4399-57ee-b9e6-f5e0f718ca6b
DOI
10.21203/rs.3.rs-3264211/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Formoterol improves the deficits of mitochondrial homeostasis including dynamic and transport in human SH-SY5Y neuroblastoma cells induced by mitochondrial UQCRC1 mutation in human neuronal SH-SY5Y cells via a β2-adrenoreceptor activationDOI 10.21203/rs.3.rs-3264211/v1
Select a neighboring publication to make it the new centre.